Literature DB >> 12112938

Diagnosing coronary artery disease in diabetic patients.

Euan A Ashley1, Vinod Raxwal, Malcolm Finlay, Victor Froelicher.   

Abstract

Although several diagnostic modalities are available to the clinician interested in diagnosing coronary artery disease, very few have been validated in diabetic populations. This review discusses the non-invasive diagnosis of coronary disease in diabetic patients. Evidence regarding the prevalence and prognostic significance of silent ischemia is reviewed and the potential impact of silent ischemia on the diagnostic characteristics of the exercise treadmill test discussed. Other diagnostic tools are considered, and recommendations are made with respect to screening asymptomatic diabetic patients for coronary artery disease. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12112938     DOI: 10.1002/dmrr.297

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  4 in total

Review 1.  Acute coronary syndromes in patients with renal failure.

Authors:  Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

2.  Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation.

Authors:  D G Jones; A M Taylor; S A Enkiri; P Lobo; K L Brayman; E C Keeley; L C Lipson; L W Gimple; M Ragosta
Journal:  Am J Transplant       Date:  2009-06-16       Impact factor: 8.086

3.  Association between erectile dysfunction and coronary artery disease and its severity.

Authors:  A Sai Ravi Shanker; B Phanikrishna; C Bhaktha Vatsala Reddy
Journal:  Indian Heart J       Date:  2013-02-24

4.  Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose.

Authors:  Ilker Tasci; Teoman Dogru; Alper Sonmez; Halil Genc; Selim Kilic; Abdullah Olgun; Mahmut Gok; Gokhan Erdem; Selahattin Erikci
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.